1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
• 1.2.1 Global Cancer Mouse Models Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Humanized Immune System Mouse Models

1.2.3 Syngeneic Tumor Mouse Models

1.2.4 Immunodeficient Mouse Models

1.2.5 NOG Mouse Models

1.2.6 Spontaneous Tumor Mouse Models

1.2.7 Others

1.3 Market by Application

1.3.1 Global Cancer Mouse Models Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Contract Research Organizations

1.3.3 Pharma and Biopharma Companies

1.3.4 Academic and Research Institutes

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Mouse Models Market Perspective (2017-2028)
• 2.2 Cancer Mouse Models Growth Trends by Region
• 2.2.1 Cancer Mouse Models Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Cancer Mouse Models Historic Market Size by Region (2017-2022)

2.2.3 Cancer Mouse Models Forecasted Market Size by Region (2023-2028)

2.3 Cancer Mouse Models Market Dynamics

2.3.1 Cancer Mouse Models Industry Trends

2.3.2 Cancer Mouse Models Market Drivers

2.3.3 Cancer Mouse Models Market Challenges

2.3.4 Cancer Mouse Models Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Mouse Models Players by Revenue
• 3.1.1 Global Top Cancer Mouse Models Players by Revenue (2017-2022)

3.1.2 Global Cancer Mouse Models Revenue Market Share by Players (2017-2022)

3.2 Global Cancer Mouse Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Mouse Models Revenue

3.4 Global Cancer Mouse Models Market Concentration Ratio

3.4.1 Global Cancer Mouse Models Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Mouse Models Revenue in 2021

3.5 Cancer Mouse Models Key Players Head office and Area Served

3.6 Key Players Cancer Mouse Models Product Solution and Service

3.7 Date of Enter into Cancer Mouse Models Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Mouse Models Breakdown Data by Type

• 4.1 Global Cancer Mouse Models Historic Market Size by Type (2017-2022)
• 4.2 Global Cancer Mouse Models Forecasted Market Size by Type (2023-2028)

5 Cancer Mouse Models Breakdown Data by Application

• 5.1 Global Cancer Mouse Models Historic Market Size by Application (2017-2022)
• 5.2 Global Cancer Mouse Models Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Cancer Mouse Models Market Size (2017-2028)
• 6.2 North America Cancer Mouse Models Market Size by Country (2017-2022)
• 6.3 North America Cancer Mouse Models Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe Cancer Mouse Models Market Size (2017-2028)
• 7.2 Europe Cancer Mouse Models Market Size by Country (2017-2022)
• 7.3 Europe Cancer Mouse Models Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Cancer Mouse Models Market Size (2017-2028)
• 8.2 Asia-Pacific Cancer Mouse Models Market Size by Country (2017-2022)
• 8.3 Asia-Pacific Cancer Mouse Models Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America Cancer Mouse Models Market Size (2017-2028)
• 9.2 Latin America Cancer Mouse Models Market Size by Country (2017-2022)
• 9.3 Latin America Cancer Mouse Models Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Cancer Mouse Models Market Size (2017-2028)
• 10.2 Middle East & Africa Cancer Mouse Models Market Size by Country (2017-2022)
• 10.3 Middle East & Africa Cancer Mouse Models Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 The Jackson Laboratory
• 11.1.1 The Jackson Laboratory Company Detail

11.1.2 The Jackson Laboratory Business Overview

11.1.3 The Jackson Laboratory Cancer Mouse Models Introduction

11.1.4 The Jackson Laboratory Revenue in Cancer Mouse Models Business (2017-2022)

11.1.5 The Jackson Laboratory Recent Development

11.2 Taconic Biosciences

11.2.1 Taconic Biosciences Company Detail

11.2.2 Taconic Biosciences Business Overview

11.2.3 Taconic Biosciences Cancer Mouse Models Introduction

11.2.4 Taconic Biosciences Revenue in Cancer Mouse Models Business (2017-2022)

11.2.5 Taconic Biosciences Recent Development

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Detail

11.3.2 Charles River Laboratories Business Overview

11.3.3 Charles River Laboratories Cancer Mouse Models Introduction

11.3.4 Charles River Laboratories Revenue in Cancer Mouse Models Business (2017-2022)

11.3.5 Charles River Laboratories Recent Development

11.4 Shanghai Model Organisms Center Inc.

11.4.1 Shanghai Model Organisms Center Inc. Company Detail

11.4.2 Shanghai Model Organisms Center Inc. Business Overview

11.4.3 Shanghai Model Organisms Center Inc. Cancer Mouse Models Introduction

11.4.4 Shanghai Model Organisms Center Inc. Revenue in Cancer Mouse Models Business (2017-2022)

11.4.5 Shanghai Model Organisms Center Inc. Recent Development

11.5 Envigo

11.5.1 Envigo Company Detail

11.5.2 Envigo Business Overview

11.5.3 Envigo Cancer Mouse Models Introduction

11.5.4 Envigo Revenue in Cancer Mouse Models Business (2017-2022)

11.5.5 Envigo Recent Development

11.6 Biocytogen

11.6.1 Biocytogen Company Detail

11.6.2 Biocytogen Business Overview

11.6.3 Biocytogen Cancer Mouse Models Introduction

11.6.4 Biocytogen Revenue in Cancer Mouse Models Business (2017-2022)

11.6.5 Biocytogen Recent Development

11.7 Genoway

11.7.1 Genoway Company Detail

11.7.2 Genoway Business Overview

11.7.3 Genoway Cancer Mouse Models Introduction

11.7.4 Genoway Revenue in Cancer Mouse Models Business (2017-2022)

11.7.5 Genoway Recent Development

11.8 Crown Bioscience Inc. (JSR Corporation).

11.8.1 Crown Bioscience Inc. (JSR Corporation). Company Detail

11.8.2 Crown Bioscience Inc. (JSR Corporation). Business Overview

11.8.3 Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Introduction

11.8.4 Crown Bioscience Inc. (JSR Corporation). Revenue in Cancer Mouse Models Business (2017-2022)

11.8.5 Crown Bioscience Inc. (JSR Corporation). Recent Development

11.9 Cyagen

11.9.1 Cyagen Company Detail

11.9.2 Cyagen Business Overview

11.9.3 Cyagen Cancer Mouse Models Introduction

11.9.4 Cyagen Revenue in Cancer Mouse Models Business (2017-2022)

11.9.5 Cyagen Recent Development

11.10 Applied stem cells

11.10.1 Applied stem cells Company Detail

11.10.2 Applied stem cells Business Overview

11.10.3 Applied stem cells Cancer Mouse Models Introduction

11.10.4 Applied stem cells Revenue in Cancer Mouse Models Business (2017-2022)

11.10.5 Applied stem cells Recent Development

11.11 Ingenious Targeting Laboratory

11.11.1 Ingenious Targeting Laboratory Company Detail

11.11.2 Ingenious Targeting Laboratory Business Overview

11.11.3 Ingenious Targeting Laboratory Cancer Mouse Models Introduction

11.11.4 Ingenious Targeting Laboratory Revenue in Cancer Mouse Models Business (2017-2022)

11.11.5 Ingenious Targeting Laboratory Recent Development

11.12 PolyGene - Transgenic mice model company

11.12.1 PolyGene - Transgenic mice model company Company Detail

11.12.2 PolyGene - Transgenic mice model company Business Overview

11.12.3 PolyGene - Transgenic mice model company Cancer Mouse Models Introduction

11.12.4 PolyGene - Transgenic mice model company Revenue in Cancer Mouse Models Business (2017-2022)

11.12.5 PolyGene - Transgenic mice model company Recent Development

11.13 Creative Biolabs

11.13.1 Creative Biolabs Company Detail

11.13.2 Creative Biolabs Business Overview

11.13.3 Creative Biolabs Cancer Mouse Models Introduction

11.13.4 Creative Biolabs Revenue in Cancer Mouse Models Business (2017-2022)

11.13.5 Creative Biolabs Recent Development

11.14 TransCure Bioservices

11.14.1 TransCure Bioservices Company Detail

11.14.2 TransCure Bioservices Business Overview

11.14.3 TransCure Bioservices Cancer Mouse Models Introduction

11.14.4 TransCure Bioservices Revenue in Cancer Mouse Models Business (2017-2022)

11.14.5 TransCure Bioservices Recent Development

11.15 Champions Oncology Inc

11.15.1 Champions Oncology Inc Company Detail

11.15.2 Champions Oncology Inc Business Overview

11.15.3 Champions Oncology Inc Cancer Mouse Models Introduction

11.15.4 Champions Oncology Inc Revenue in Cancer Mouse Models Business (2017-2022)

11.15.5 Champions Oncology Inc Recent Development

11.16 Certis Oncology

11.16.1 Certis Oncology Company Detail

11.16.2 Certis Oncology Business Overview

11.16.3 Certis Oncology Cancer Mouse Models Introduction

11.16.4 Certis Oncology Revenue in Cancer Mouse Models Business (2017-2022)

11.16.5 Certis Oncology Recent Development

11.17 Signature

11.17.1 Signature Company Detail

11.17.2 Signature Business Overview

11.17.3 Signature Cancer Mouse Models Introduction

11.17.4 Signature Revenue in Cancer Mouse Models Business (2017-2022)

11.17.5 Signature Recent Development

11.18 Pharmaron

11.18.1 Pharmaron Company Detail

11.18.2 Pharmaron Business Overview

11.18.3 Pharmaron Cancer Mouse Models Introduction

11.18.4 Pharmaron Revenue in Cancer Mouse Models Business (2017-2022)

11.18.5 Pharmaron Recent Development

11.19 Laboratory Corporation of America Holdings

11.19.1 Laboratory Corporation of America Holdings Company Detail

11.19.2 Laboratory Corporation of America Holdings Business Overview

11.19.3 Laboratory Corporation of America Holdings Cancer Mouse Models Introduction

11.19.4 Laboratory Corporation of America Holdings Revenue in Cancer Mouse Models Business (2017-2022)

11.19.5 Laboratory Corporation of America Holdings Recent Development

11.20 Gempharmatech

11.20.1 Gempharmatech Company Detail

11.20.2 Gempharmatech Business Overview

11.20.3 Gempharmatech Cancer Mouse Models Introduction

11.20.4 Gempharmatech Revenue in Cancer Mouse Models Business (2017-2022)

11.20.5 Gempharmatech Recent Development

11.21 Janvier Labs

11.21.1 Janvier Labs Company Detail

11.21.2 Janvier Labs Business Overview

11.21.3 Janvier Labs Cancer Mouse Models Introduction

11.21.4 Janvier Labs Revenue in Cancer Mouse Models Business (2017-2022)

11.21.5 Janvier Labs Recent Development

11.22 Harbour BioMed

11.22.1 Harbour BioMed Company Detail

11.22.2 Harbour BioMed Business Overview

11.22.3 Harbour BioMed Cancer Mouse Models Introduction

11.22.4 Harbour BioMed Revenue in Cancer Mouse Models Business (2017-2022)

11.22.5 Harbour BioMed Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
• 13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

Industry Insights
The global Cancer Mouse Models market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Humanized Immune System Mouse Models accounting for % of the Cancer Mouse Models global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Contract Research Organizations segment is altered to an % CAGR throughout this forecast period.

China Cancer Mouse Models market size is valued at US$ million in 2021, while the North America and Europe Cancer Mouse Models are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cancer Mouse Models landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Mouse Models market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Mouse Models market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Mouse Models market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Mouse Models market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Cancer Mouse Models market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Cancer Mouse Models Breakdown Data by Type

Humanized Immune System Mouse Models

Syngeneic Tumor Mouse Models

Immunodeficient Mouse Models

NOG Mouse Models

Spontaneous Tumor Mouse Models

Others

Cancer Mouse Models Breakdown Data by Application

Contract Research Organizations

Pharma and Biopharma Companies

Academic and Research Institutes

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

The Jackson Laboratory

Taconic Biosciences

Charles River Laboratories

Shanghai Model Organisms Center Inc.

Envigo

Biocytogen

Genoway

Crown Bioscience Inc. (JSR Corporation).

Cyagen

Applied stem cells

Ingenious Targeting Laboratory

PolyGene - Transgenic mice model company

Creative Biolabs

TransCure Bioservices

Champions Oncology Inc

Certis Oncology

Signature

Pharmaron

Laboratory Corporation of America Holdings

Gempharmatech

Janvier Labs

Harbour BioMed

Frequently Asked Questions

What factors will challenge the Cancer Mouse Models market growth?

Which end-use segment will expand at the fastest CAGR in the Cancer Mouse Models market?

Which are the emerging players in the Cancer Mouse Models market?

How concentrated is the Cancer Mouse Models market?

Which factors are positively contributing to the Cancer Mouse Models market growth?

Which are the novel product innovations in the Cancer Mouse Models market?

Which product segment will emerge as the most lucrative in the Cancer Mouse Models market?

Which factors are increasing the competition in the Cancer Mouse Models market?

Which are the strategic measures taken by the Cancer Mouse Models industry players?

Which region will witness inactive growth during the forecast period?

What key trends are likely to emerge in the Cancer Mouse Models market in the coming years?